Literature DB >> 21414072

Lasers in the treatment of nonmelanoma skin cancer.

Sonal Choudhary1, Jennifer Tang, Mohamed L Elsaie, Keyvan Nouri.   

Abstract

BACKGROUND: Nonmelanoma skin cancers (NMSCs) constitute the largest proportion of cancers worldwide, especially in the Western population, making it essential to develop methods to manage these cancers. Ultraviolet (UV) light being the most significant culprit in the development of NMSCs makes the sun-exposed parts of the body, such as face and extremities, the most vulnerable to develop these tumors. Early diagnosis and emphasis on cosmesis are vital while treating them especially, in patients with multiple squamous and basal cell carcinomas. Lasers seem to be a useful therapeutic modality and are being explored to develop them as a tool for treating skin cancers.
OBJECTIVE: To review the use of lasers in the treatment of NMSCs.
METHODS: We reviewed articles that involved the use of lasers in the management of NMSCs and prepared a critical analysis of the same. RESULTS AND
CONCLUSIONS: Lasers as a single modality, as the coherent light source in photodynamic therapy (PDT), or as an adjunct to PDT or other treatment modalities are a potential method of NMSC eradication. Superficial NMSCs and most precancerous cutaneous lesions such as Bowen's disease and actinic keratoses respond best, whereas deeper, more-aggressive NMSCs show poor outcomes with laser treatments.
© 2011 by the American Society for Dermatologic Surgery, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21414072     DOI: 10.1111/j.1524-4725.2011.01928.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  9 in total

Review 1.  Fibroblast senescence and squamous cell carcinoma: how wounding therapies could be protective.

Authors:  Jeffrey B Travers; Dan F Spandau; Davina A Lewis; Christiane Machado; Melanie Kingsley; Nico Mousdicas; Ally-Khan Somani
Journal:  Dermatol Surg       Date:  2013-02-25       Impact factor: 3.398

Review 2.  Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.

Authors:  Priyadharsini Nagarajan; Maryam M Asgari; Adele C Green; Samantha M Guhan; Sarah T Arron; Charlotte M Proby; Dana E Rollison; Catherine A Harwood; Amanda Ewart Toland
Journal:  Clin Cancer Res       Date:  2018-12-06       Impact factor: 12.531

Review 3.  Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.

Authors:  Julien Lanoue; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

4.  Confocal microscopy to guide erbium:yttrium aluminum garnet laser ablation of basal cell carcinoma: an ex vivo feasibility study.

Authors:  Heidy Sierra; Bjorg A Larson; Chih-Shan Jason Chen; Milind Rajadhyaksha
Journal:  J Biomed Opt       Date:  2013-09       Impact factor: 3.170

Review 5.  Melanoma resistance to photodynamic therapy: new insights.

Authors:  Ying-Ying Huang; Daniela Vecchio; Pinar Avci; Rui Yin; Maria Garcia-Diaz; Michael R Hamblin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

6.  Confocal microscopy-guided laser ablation for superficial and early nodular Basal cell carcinoma: a promising surgical alternative for superficial skin cancers.

Authors:  Chih-Shan Jason Chen; Heidy Sierra; Miguel Cordova; Milind Rajadhyaksha
Journal:  JAMA Dermatol       Date:  2014-09       Impact factor: 10.282

7.  Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin.

Authors:  Dan F Spandau; Davina A Lewis; Ally-Khan Somani; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2012-03-01       Impact factor: 8.551

8.  Pulsed dye laser does not seem as effective as red light in Basal cell carcinoma mal-pdt: a small pilot study.

Authors:  M Fernández-Guarino; A Harto; P Jaén
Journal:  J Skin Cancer       Date:  2012-10-31

9.  Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis.

Authors:  Fiona M Frame; Huguette Savoie; Francesca Bryden; Francesca Giuntini; Vincent M Mann; Matthew S Simms; Ross W Boyle; Norman J Maitland
Journal:  Cancer Med       Date:  2015-11-21       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.